Alan

  • Following

    0

  • Followers

    0

No Bio yet.
Joined Jan 2023

Comments

Alan commented on CMSB.
He is one of the board member since many years. BoD can check the account anytime. Why making it a fuss?
2 months · translate
Alan commented on GENTING.
Genting's investment in TauRx Pharmaceuticals focuses on the development of hydromethylthionine mesylate (HMTM), not a vaccine. The drug recently completed Phase 3 clinical trials, showing promising results. Approval could allow public availability as early as 2025 if regulatory milestones are met. Refer sources :TauRx official website.
5 months · translate
Alan replied to comment on CMSB.
Analysis spot on. Current price is undervalued. Invested for mid term (2Q period) gain. Be patient.
5 months · translate
Alan commented on SPSETIA.
Big institution fund selling. SPsetia Legal proceeding against management, which will drag for sometime as usual legal battles in malaysia.
9 months · translate
Load more